The U.S. government invests nearly $150B each year in federal R&D for cutting edge research at federal labs and universities across the country, as well as small business research and commercialization efforts. As a result of this investment, companies and entrepreneurs may find resources — including research facilities and licensing and funding opportunities — that can support the response to COVID-19. NIST’s Technology Partnership Office has identified the following online resources:
Search FLC Business for Federal laboratory information related to COVID-19. This includes technologies available for licensing, laboratory facilities and equipment, funding opportunities, and lab-specific special programs.
The USPTO's IP Marketplace Platform includes over 200 patents related to the prevention, diagnosis, and treatment of COVID-19.
AUTM's Innovation Marketplace provides a list of available technologies related to COVID-19.
NIST's MEP centers are supporting U.S. manufacturers as they respond to COVID-19. Learn about the many ways the centers are responding.
The Small Business Administration provides information on SBIR awards related to COVID-19.